These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 16084160)

  • 1. Prognostic significance of circulating levels of angiogenic cytokines in patients with congestive heart failure.
    Lamblin N; Susen S; Dagorn J; Mouquet F; Jude B; Van Belle E; Bauters C; de Groote P
    Am Heart J; 2005 Jul; 150(1):137-43. PubMed ID: 16084160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum hepatocyte growth factor and vascular endothelial growth factor in children with acute liver failure.
    Aw MM; Mitry RR; Hughes RD; Dhawan A
    J Pediatr Gastroenterol Nutr; 2007 Feb; 44(2):224-7. PubMed ID: 17255836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating angiogenic cytokines in multiple myeloma and related disorders.
    Urba ska-Rys H; Wierzbowska A; Robak T
    Eur Cytokine Netw; 2003; 14(1):40-51. PubMed ID: 12799213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum hepatocyte growth factor levels predict long-term clinical outcome after percutaneous coronary revascularization.
    Susen S; Sautière K; Mouquet F; Cuilleret F; Chmaït A; McFadden EP; Hennache B; Richard F; de Groote P; Lablanche JM; Dallongeville J; Bauters C; Jude B; Van Belle E
    Eur Heart J; 2005 Nov; 26(22):2387-95. PubMed ID: 16105849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocyte growth factor is a strong predictor of mortality in patients with advanced heart failure.
    Rychli K; Richter B; Hohensinner PJ; Kariem Mahdy A; Neuhold S; Zorn G; Berger R; Mörtl D; Huber K; Pacher R; Wojta J; Niessner A; Hülsmann M
    Heart; 2011 Jul; 97(14):1158-63. PubMed ID: 21572126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic utility of growth differentiation factor-15 in patients with chronic heart failure.
    Kempf T; von Haehling S; Peter T; Allhoff T; Cicoira M; Doehner W; Ponikowski P; Filippatos GS; Rozentryt P; Drexler H; Anker SD; Wollert KC
    J Am Coll Cardiol; 2007 Sep; 50(11):1054-60. PubMed ID: 17825714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum levels of endostatin, vascular endothelial growth factor (VEGF) and hepatocyte growth factor (HGF) in patients with acute myocardial infarction undergoing early reperfusion therapy.
    Seko Y; Fukuda S; Nagai R
    Clin Sci (Lond); 2004 May; 106(5):439-42. PubMed ID: 14965340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased angiogenic growth factor in cyanotic congenital heart disease.
    Himeno W; Akagi T; Furui J; Maeno Y; Ishii M; Kosai K; Murohara T; Kato H
    Pediatr Cardiol; 2003; 24(2):127-32. PubMed ID: 12360391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-sensitivity C-reactive protein: potential adjunct for risk stratification in patients with stable congestive heart failure.
    Lamblin N; Mouquet F; Hennache B; Dagorn J; Susen S; Bauters C; de Groote P
    Eur Heart J; 2005 Nov; 26(21):2245-50. PubMed ID: 16183690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of plasma erythropoietin on mortality in patients with chronic heart failure.
    van der Meer P; Voors AA; Lipsic E; Smilde TD; van Gilst WH; van Veldhuisen DJ
    J Am Coll Cardiol; 2004 Jul; 44(1):63-7. PubMed ID: 15234408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelial activation, dysfunction, and damage in congestive heart failure and the relation to brain natriuretic peptide and outcomes.
    Chong AY; Freestone B; Patel J; Lim HS; Hughes E; Blann AD; Lip GY
    Am J Cardiol; 2006 Mar; 97(5):671-5. PubMed ID: 16490435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum hepatocyte growth factor levels are increased in patients with congestive heart failure.
    Ueno S; Ikeda U; Hojo Y; Arakawa H; Nonaka M; Yamamoto K; Shimada K
    J Card Fail; 2001 Dec; 7(4):329-34. PubMed ID: 11782856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatocyte growth factor and vascular endothelial growth factor in ischaemic heart disease.
    Suzuki H; Murakami M; Shoji M; Iso Y; Kondo T; Shibata M; Ezumi H; Hamazaki Y; Koba S; Katagiri T
    Coron Artery Dis; 2003 Jun; 14(4):301-7. PubMed ID: 12826929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure.
    Kistorp C; Faber J; Galatius S; Gustafsson F; Frystyk J; Flyvbjerg A; Hildebrandt P
    Circulation; 2005 Sep; 112(12):1756-62. PubMed ID: 16157772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between serum levels of vascular endothelial growth factor, hepatocyte growth factor and matrix metalloproteinase-9 with biochemical markers of bone disease in multiple myeloma.
    Alexandrakis MG; Sfiridaki A; Miyakis S; Pappa C; Kandidaki E; Alegakis A; Margioris AN
    Clin Chim Acta; 2007 Apr; 379(1-2):31-5. PubMed ID: 17234170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Basic fibroblast growth factor (bFGF) and vascular endothelial growth factor (VEGF) are elevated in peripheral blood plasma of patients with chronic lymphocytic leukemia and decrease after intensive fludarabine-based treatment].
    Smolej L; Andrýs C; Krejsek J; Belada DZ; Zák P; Siroký O; Malý J
    Vnitr Lek; 2007 Nov; 53(11):1171-6. PubMed ID: 18277626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma angiopoietin-1, angiopoietin-2, and angiopoietin receptor tie-2 levels in congestive heart failure.
    Chong AY; Caine GJ; Freestone B; Blann AD; Lip GY
    J Am Coll Cardiol; 2004 Feb; 43(3):423-8. PubMed ID: 15013125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased growth factor expression after hepatic and pancreatic resection.
    Justinger C; Schlüter C; Oliviera-Frick V; Kopp B; Rubie C; Schilling MK
    Oncol Rep; 2008 Dec; 20(6):1527-31. PubMed ID: 19020737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating endothelial progenitor cells in congestive heart failure.
    Nonaka-Sarukawa M; Yamamoto K; Aoki H; Nishimura Y; Tomizawa H; Ichida M; Eizawa T; Muroi K; Ikeda U; Shimada K
    Int J Cardiol; 2007 Jul; 119(3):344-8. PubMed ID: 17070610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anabolic deficiency in men with chronic heart failure: prevalence and detrimental impact on survival.
    Jankowska EA; Biel B; Majda J; Szklarska A; Lopuszanska M; Medras M; Anker SD; Banasiak W; Poole-Wilson PA; Ponikowski P
    Circulation; 2006 Oct; 114(17):1829-37. PubMed ID: 17030678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.